KATELYN CUNDARI: Open Payments
NPI 1235774985 · BIRDSBORO, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,455 in 66 payments from 15 companies in 2025. Trend: 2023 $1,704 · 2024 $1,579 · 2025 $1,455
Food & beverage: $1,373Education: $82
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $331 |
| Janssen Biotech, Inc. | 9 | $297 |
| Galderma Laboratories, L.P. | 14 | $229 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $111 |
| GENZYME CORPORATION | 3 | $95 |
| UCB, Inc. | 3 | $85 |
| Novartis Pharmaceuticals Corporation | 3 | $69 |
| Organon LLC | 3 | $61 |
| PFIZER INC. | 3 | $52 |
| Lilly USA, LLC | 1 | $25 |
Products named: TREMFYA, RINVOQ, SKYRIZI, NEMLUVIO, DUPIXENT, Bimzelx, AKLIEF, CIBINQO.
Industry payments across PA — which companies pay providers there.
